Advertisement

Topics

Carcinoid Cancer Foundation Company Profile

00:19 EDT 23rd October 2017 | BioPortfolio


News Articles [2797 Associated News Articles listed on BioPortfolio]

Midatech files CTA for MTD201’s carcinoid cancer and acromegaly trial

UK-based specialist pharmaceutical firm Midatech Pharma has submitted a clinical trial application (CTA) for its drug candidate MTD201 to treat carcinoid cancer and acromegaly.

Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly

Midatech Pharma has announced the submission of a clinical trial application (CTA) for a first in human study of its MTD201 programme in carcinoid cancer and acromegaly.

Carcinoid Syndrome Management market is estimated to grow at 7% CAGR by 2022

Major Key Players are Novartis International AG, Pharmascience Inc. , Omega Laboratories Ltd. , Teva Pharmaceutical Industries Ltd. , Mylan N.V. , " The global Carcinoid Syndrome Management market has...

Drug gains expanded approval for carcinoid syndrome

Ipsen Biopharmaceuticals' injectable Somatuline Depot, or lanreotide, received expanded FDA approval for carcinoid syndrome a -More- 

EC Approves Ipsen's Xermelo for Carcinoid Syndrome Treatment

NewsIpsen receives approval from European Commission for Xermelo (telotristat ethyl) for the treatment of carcinoid syndrome diarrhea in patients inadequately controlled by somatostatin analogue thera...

Stand Up To Cancer, Lustgarten Foundation Award $2M to Pancreatic Cancer Research Team

Stand Up To Cancer has partnered with the Lustgarten Foundation for Pancreatic Cancer Research to sponsor a translational research team focused on applying chimeric antigen receptor T cell (CAR-T) the...

Damon Runyon Cancer Research Foundation awards over $3.1M to top clinical investigators

(Damon Runyon Cancer Research Foundation) The Damon Runyon Cancer Research Foundation named five new Damon Runyon Clinical Investigators at its spring 2017 committee review. The recipients of this pre...

Ipsen gets EC approval for Xermelo to treat carcinoid syndrome diarrhea

Ipsen announced that the European Commission (EC) has approved Xermelo (telotristat ethyl) 250 mg three times a day (tid) for the treatment of carcinoid syndrome diarrhea in combination with somatost...

Drugs and Medications [715 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [6511 Associated PubMed Articles listed on BioPortfolio]

Cushing's syndrome secondary to typical pulmonary carcinoid with mutation in BCOR gene: A case report.

Typical pulmonary carcinoid is a kind of low-grade malignancy neuroendocrine tumor. Cushing's syndrome is a very rare clinical feature of typical pulmonary carcinoid caused by hypercorticism. Complete...

A rare case of primary ovarian carcinoid.

We present a rare case in an elderly Caucasian lady of primary ovarian carcinoid tumor, causing symptoms of the carcinoid syndrome and severe carcinoid heart disease. Carcinoid tumors are the commones...

Surgical Intervention in Gastric Carcinoid is Associated With Improved Survival in Local and Regional Disease.

Gastric carcinoid is a rare entity with complex management options. This study aims to determine if surgical intervention in patients with local, regional, and metastatic gastric carcinoid is associat...

OUTCOME OF LIVER RESECTION FOR CARCINOID NEUROENDOCRINE METASTASES.

Gastrointestinal carcinoid tumours, despite their low malignant potential, frequently metastasize to the liver. While liver resection improves survival and provides symptomatic relief, multifocal bilo...

Pediatric Neuroendocrine Carcinoid Tumors: Review of Diagnostic Imaging Findings and Recent Advances.

Although rare, pediatric neuroendocrine tumors including carcinoid tumor have increased in incidence over the past few decades. Despite increased recognition, survival rates have not significantly imp...

Clinical Trials [6682 Associated Clinical Trials listed on BioPortfolio]

Study Investigating MEN1 and SDHD in Familial Carcinoid Tumors

There is a high incidence among the first degree relatives of the carcinoid patients, indicating the involvement of genetic components in its initiation and pathogenesis.

Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

This is a prospective phase II open-label trial, stratifying patients equally into two cohorts consisting of carcinoid tumors and pancreatic neuroendocrine tumors (pNETs). The purpose of t...

EPO906 in Carcinoid and Other Neuroendocrine Tumors

This study will examine whether the new investigational drug EPO906, given by intravenous infusion (IV directly into the vein), is effective in shrinking tumors and preventing the growth o...

An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome

The purpose of this study is to determine whether monthly injections of Somatuline Depot are effective and safe in controlling diarrhea and flushing in patients with carcinoid syndrome.

An Investigation of Small Intestinal Carcinoid Carcinoma in Families

This proposed pilot study is to conduct detailed interviews into the medical, environmental, and family histories The second phase of this study project is to and to collect blood specimen...

Companies [2592 Associated Companies listed on BioPortfolio]

Carcinoid Cancer Foundation

The Carcinoid Cancer Foundation

Caring for Carcinoid Foundation

Kids Who Care Foundation

The Kids Who Care Foundation, based in Orange County, California, is 501-3c non-profit organization which is run by a 100% volunteer effort. After being in and out of hospi...

Sky Foundation, Inc.

After being diagnosed with pancreatic cancer in 2007 and responding well to treatment, Kasselman established Sky Foundation to fund research for the Sky Foundation Pancreatic Cancer Research Fund at t...

More Information about "Carcinoid Cancer Foundation" on BioPortfolio

We have published hundreds of Carcinoid Cancer Foundation news stories on BioPortfolio along with dozens of Carcinoid Cancer Foundation Clinical Trials and PubMed Articles about Carcinoid Cancer Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Carcinoid Cancer Foundation Companies in our database. You can also find out about relevant Carcinoid Cancer Foundation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record